Literature DB >> 3934475

Tube feeding of cancer patients treated with chemotherapy.

E G de Vries, W M Kreumer, D L Schippers, N H Mulder.   

Abstract

As many chemotherapeutic agents affect the alimentary tract the use of hyperalimentation with tube feeding during and after chemotherapy has been limited. However, patients do tolerate tube feeding well despite chemotherapy. The feeding has to be administered as continuous drip infusion and in case of bone marrow depression sterile feeding is necessary. Enteral nutrition is more physiologic, safer, easier and less expensive than parenteral nutrition. With enteral hyperalimentation the nutritional needs can be fulfilled to a large extent. Much research will be necessary to investigate the effect of enteral (hyper)alimentation on tumor metabolism and clinical effect of chemotherapy.

Entities:  

Mesh:

Year:  1985        PMID: 3934475     DOI: 10.1007/bf02934551

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  29 in total

1.  The effect of continuous enteral tube feeding on various nutritional parameters in patients with disseminated malignant melanoma during intensive chemotherapy.

Authors:  J M Smit; N H Mulder; D T Sleijfer; J G Bouman; W Veeger; H Schraffordt Koops
Journal:  Clin Nutr       Date:  1983-03       Impact factor: 7.324

2.  Skeletal muscle metabolism in patients with malignant tumor.

Authors:  K Lundholm; A C Bylund; J Holm; T Scherstén
Journal:  Eur J Cancer       Date:  1976-06       Impact factor: 9.162

Review 3.  Energy metabolism and requirements in the cancer patient.

Authors:  V R Young
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

4.  Effect of chemotherapy on taste sensation in patients with disseminated malignant melanoma.

Authors:  N H Mulder; J M Smit; W M Kreumer; J Bouman; D T Sleijfer; W Veeger; H Schraffordt Koops
Journal:  Oncology       Date:  1983       Impact factor: 2.935

5.  Continuous enteric alimentation with a blenderized formula in cancer cachexia.

Authors:  J B Block; R T Chlebowski; J N Herrold
Journal:  Clin Oncol       Date:  1981-06

6.  Controlled clinical trials of nutritional intervention as an adjunct to chemotherapy, with a comment on nutrition and drug resistance.

Authors:  A S Levine; M F Brennan; A Ramu; R I Fisher; P A Pizzo; D L Glaubiger
Journal:  Cancer Res       Date:  1982       Impact factor: 12.701

7.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

8.  Enteral nutrition by nasogastric tube in adult patients treated with intensive chemotherapy for acute leukemia.

Authors:  E G de Vries; N H Mulder; B Houwen; H G de Vries-Hospers
Journal:  Am J Clin Nutr       Date:  1982-06       Impact factor: 7.045

9.  High remission-induction rate in acute myeloid leukaemia.

Authors:  R P Gale; M J Cline
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

10.  A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.

Authors:  M B Popp; R I Fisher; R M Simon; M F Brennan
Journal:  Cancer Treat Rep       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.